[
    [
        {
            "time": "2018-01-03",
            "original_text": "Assessing Pfizer’s 4Q17 Quarterly Revenue Trend",
            "features": {
                "keywords": [
                    "Pfizer",
                    "4Q17",
                    "Quarterly",
                    "Revenue",
                    "Trend"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Assessing Pfizer’s 4Q17 Quarterly Revenue Trend",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 3,
                "Time_Proximity": 4,
                "Headline_Structure": 7,
                "Source_Recency": 3
            }
        },
        {
            "time": "2018-01-05",
            "original_text": "Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns",
            "features": {
                "keywords": [
                    "Diabetes",
                    "Devices",
                    "Market",
                    "Stocks",
                    "Returns"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "medical devices"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Diabetes Devices Market on a Tear: 3 Stocks for Solid Returns",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "2018-01-08",
            "original_text": "Noteworthy ETF Inflows: IHI, ABT, BDX, SYK",
            "features": {
                "keywords": [
                    "ETF",
                    "Inflows",
                    "IHI",
                    "ABT",
                    "BDX",
                    "SYK"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Noteworthy ETF Inflows: IHI, ABT, BDX, SYK",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 7,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2018-03-14",
            "original_text": "Capitol to Capital: Cramer's 'Mad Money' Recap (Wednesday 3/14/18)",
            "features": {
                "keywords": [
                    "Capitol",
                    "Capital",
                    "Cramer",
                    "Mad Money",
                    "Recap"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "general market"
                ],
                "causal_factor": "true",
                "causal_impact": "neutral",
                "affected_by_time_series": "true",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "Capitol to Capital: Cramer's 'Mad Money' Recap (Wednesday 3/14/18)",
                "Correlation": 5,
                "Sentiment": 5,
                "Importance": 5,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 4,
                "Market_Scope": 6,
                "Time_Proximity": 3,
                "Headline_Structure": 8,
                "Source_Recency": 2
            }
        }
    ]
]